Rho kinase inhibition and vascular protection: support from studies in Bartter and Gitelman syndrome.
Calò
Lorenzo A
LA
Pagnin
Elisa
E
Davis
Paul A
PA
Sartori
Michelangelo
M
Semplicini
Andrea
A
Pessina
Achille C
AC
D001477:Bartter Syndrome / Q000188:drug therapy*; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D006801:Humans; D047908:Intracellular Signaling Peptides and Proteins; D019001:Nitric Oxide Synthase / Q000235:genetics*; D052250:Nitric Oxide Synthase Type III; D017346:Protein Serine-Threonine Kinases / Q000037:antagonists & inhibitors*; D054460:rho-Associated Kinases
D004791:Enzyme Inhibitors; D047908:Intracellular Signaling Peptides and Proteins; C496314:NOS3 protein, human; D019001:Nitric Oxide Synthase; D052250:Nitric Oxide Synthase Type III; D017346:Protein Serine-Threonine Kinases; D054460:rho-Associated Kinases